Noveris Health Sciences Inc. Stock Price

CNSX:NVRS Community·CA$172.7m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create Narrative

NVRS Share Price Performance

CA$2.18

1.93 (772.00%)

CA$2.18

1.93 (772.00%)

CA$2.18

Wed, 10 Jun 26

Share Pricen/a

NVRS Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Medium-low risk with questionable track record.

6 Risks

1 Reward

View Full Analysis

Noveris Health Sciences Inc. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.027
: 0%
: 0%
: -18.8%

View Full Analysis

About NVRS

Founded: 2013
Employees: n/a
CEO: Jason Birmingham
WebsiteView website: noveris.health

Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.